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Abstract
During a Escherichia coli O157 prevalence study on cattle farms, 324 E. coli O157 isolates were collected from 68
out of 180 cattle farms. All isolates harbored the eaeA gene and the enterohemolysin (ehxA) gene. The majority of
the strains only contained vtx2 (245 isolates), the combination of vtx1 and vtx2 was detected in 50 isolates, and in
29 isolates none of the vtx genes was present. Pulsed-field gel electrophoresis (PFGE) revealed that at a similarity
level of 98% the isolates grouped into 83 different genotypes, 76 of which were only detected on one farm.
Twenty-two out of the 68 positive farms harbored isolates belonging to more than one PFGE type, with a
maximum of four different PFGE types. Minimal inhibitory concentrations of 10 antimicrobial agents were
determined on a subset of 116 isolates, that is, one isolate per positive age category per farm. Acquired resistance
to at least one antimicrobial agent was detected in 18 isolates and within a farm, only one resistance pattern was
observed. All these 18 isolates were resistant toward streptomycin, and 16 of them also showed resistance
toward sulfisoxazole. Six isolates were resistant to three or more antimicrobial agents.
Introduction
Enterohemorrhagic Escherichia coli O157 have beenrecognized as an important cause of hemorrhagic colitis
and hemolytic uremic syndrome (HUS) (Griffin, 1995). The
most important virulence characteristic is the production of
one or more types of verocytotoxins, although several other
virulence factors may contribute to the pathogenicity of these
bacteria. Intimin, encoded by the eaeA gene that is located
within the locus for enterocyte effacement pathogenicity is-
land, is responsible for the intimate attachment to intestinal
cells and causes attaching-and-effacing lesions in the intesti-
nal mucosa (McDaniel and Kaper, 1997). Moreover, a plas-
mid-encoded enterohemolysin (ehxA), which acts as a pore-
forming cytolysin on eukaryotic cells, may play a role in
pathogenesis (Nataro and Kaper, 1998). The high virulence
combined with the low infection dose make infections in
humans particularly severe and life threatening (Griffin et al.,
1994; Tilden et al., 1996).
One of the most contentious areas in the management of E.
coli O157 infections in humans lies in the possible effect that
antimicrobials may have on the evolution of the infection.
Because antimicrobials may cause increased expression of vtx
in vivo (Zhang et al., 2000) and=or lysis of the bacterial cell
walls, thereby liberating vtx (Walterspiel et al., 1992; Wong
et al., 2000), they are not recommended for treating E. coliO157
infections in humans. However, there are studies suggesting
that some antimicrobials, if administered early in the course of
infection, may prevent disease progression to HUS (Fukush-
ima et al., 1999; Ikeda et al., 1999). Although many E. coliO157
isolates are susceptible to several antimicrobials, recent re-
ports indicate that, like in other foodborne pathogens, anti-
microbial resistant strains of E. coliO157 emerge (Farina et al.,
1996; Galland et al., 2001; Schroeder et al., 2002). Such strains
can reach humans via the consumption of contaminated meat
(Sørum and L’Abe´e-Lund, 2002) andmay represent a threat to
human health.
Genetic fingerprinting is an epidemiological tool that has
often been used to identify probable sources of infections.
Additionally, this approach has also been used to understand
the ecology of E. coli O157 and might be used as a part of
intervention strategies to reduce on-farm pathogens. From
various methods available for genetic characterization of
bacterial isolates, pulsed-field gel electrophoresis (PFGE) has
been used successfully in the past for E. coli O157 and is
considered as the gold standard to fingerprint E. coli O157
strains (Swaminathan et al., 2001).
Although PFGE is usedworldwide to determine the genetic
diversity of animal E. coli O157 strains, the number of isolates
typed is often limited or they originated from a limited
number of farms. The aim of the present studywas to evaluate
the genotypic diversity of E. coli O157 isolates within and
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between cattle farms (dairy, beef, and mixed farms). Ad-
ditionally, the isolates were further characterized by their
virulence genes profile and antimicrobial resistance.
Materials and Methods
Sample collection and microbiological analysis
E. coli O157 isolates (n¼ 324) were collected during a
prevalence study on 180 cattle farms (dairy: n¼ 49, beef:
n¼ 75, mixed: n¼ 45 and veal: n¼ 11) in the northern part of
Belgium (Cobbaut et al., 2009). On each of these farms the
bedding material in the pens was sampled by the overshoe
method (Cobbaut et al., 2008). Within a farm, pens harboring
the three following age categories were sampled if present:<8
months, 8–30 months, and >30 months.
E. coli O157 was isolated by enrichment in modified tryp-
tone soya broth (Oxoid, Basingstoke, United Kingdom),
supplemented with novobiocin (20mg=L; Sigma-Aldrich, St.
Louis, MO) during 6 hours at 428C, followed by selective
plating on sorbitol MacConky agar (Oxoid) supplemented
with cefixime (0.05mg=L; Invitrogen, Paisley, United King-
dom) and potassium tellurite (2.5mg=L; Invitrogen) after
immunomagnetic separation. After 24 hours of incubation at
428C, up to three suspected sorbitol-negative colonies were
picked from each selective plate and further tested for the
presence of the O157 antigen using the E. coli O157 Latex kit
from Oxoid. A maximum of nine agglutination-positive iso-
lates per farm were selected (three of each sampled age cate-
gory) for serotype confirmation by PCR (Cobbaut et al., 2009)
and further characterization.
Identification of the virulence factor genes
For each isolate identified as E. coli O157, a multiplex PCR
was performed using the primers for vtx1, eaeA, and ehxA as
described by Fagan et al. (1999) and for vtx2 as described by
Paton and Paton (1998). PCR assays were carried out in a
25 mL volume containing 1 mL of the lysates, 1 Taq buffer
(20mM Tris-HCl, pH 8.0, and 50mM KCl), 0.75U Taq DNA
polymerase, 500 mMdNTPs, 3mMofMgCl2, and 1.5 mMof the
vtx1, eaeA, and ehxA and 0.6 mM of the vtx2 primers.
Temperature conditions consisted of an initial 958C dena-
turation step for 3 minutes, followed by 30 cycles at 958C for
20 seconds, 588C for 40 seconds, and 728C for 90 seconds. The
last cycle was followed by an 8-minute elongation at 728C and
a final hold at 48C. PCR amplification products were analyzed
by electrophoresis in 1.5% agarose gels.
Pulsed-field gel electrophoresis
PFGE was performed to analyze the genetic relatedness of
the studied isolates using the standardized method of the
PulseNet (2007). The agarose-embedded DNA was digested
in the agarose plugs with XbaI (Invitrogen). The resulting
fragments were separated by a ChefMapper (Biorad, Marne
La Coquette, France) in a 1% Seakem Gold agarose gel (Bio-
whittaker Molcular Applications, Rockland, ME). The elec-
trophoresis conditions were as follows: auto algorithm;
molecular weight: low, 300K–high, 6000K; calibration factor:
1.00; 0.5 TBE, 148C, 1.0% SeaKem Gold agarose; gradient:
6 V=cm at 148C; run time: 18 hours; included angle: 1208;
initial switch time: 2.2 seconds; final switching time: 54.2
seconds; ramping factor: linear. After electrophoresis, the gel
was stained with ethidium bromide and digitally captured
under UV light.
PFGE profiles were clusteredwith GelCompar 3.0 (Applied
Maths, Sint-Marten-Latem, Belgium) using the Dice coeffi-
cient (1% position tolerance) and the unweighted-pair group
method using arithmetic averages algorithm. Each PFGE ge-
notype (defined as a similarity of <98%) was assigned an
arbitrary number.
Antimicrobial susceptibility testing
A collection of 116 isolates were analyzed for antimicrobial
resistance. From each farm, one isolate from each positive age
category was randomly selected. A quantitative agar dilution
test on Mueller Hinton II agar (Becton Dickinson Company,
Cockeysville, MD) was performed according to Clinical and
Laboratory Standards Institute guidelines (CLSI, 2008).
Minimal inhibitory concentrations (MIC) of ampicillin,
amoxicillin=clavulanic acid, ceftiofur, chloramphenicol, en-
rofloxacin, gentamicin, streptomycin, sulfisoxazole, trimeth-
oprim, and tetracycline were determined by incorporating
twofold dilutions of these antimicrobials in the Mueller Hin-
ton II agar plates. Concentrations ranged from 0.03 to
128 mg=mL except for sulfisoxazole, for which concentrations
of 256, 512, and 1024mg=mL were additionally tested. Over-
night cultures were inoculated in Brain Heart Infusion Broth
(Oxoid). Suspensions were aerobically incubated overnight at
358C. Starting from the latter cultures, phosphate buffered
saline (PBS) suspensions of 0.5 McFarland were made. Before
inoculation on the antimicrobial-containing plates using the
Denley Multipoint Inoculator (Mast, Bootle, United King-
dom), 1=10 dilutions in PBSwere prepared. E. coliATCC25922
and Staphylococcus aureus ATCC 29213 were used as control
strains. MIC values were recorded after aerobic incubation at
358C during 16–20 hours.
Results were interpreted by evaluating the distribution of
the MIC values of a specific antimicrobial agent for all tested
strains. In addition, the clinical breakpoints as recommended
by the CLSI or, if not available, the wild-type cut-off values
described by the European Committee on Antimicrobial Sus-
ceptibility Testing (EUCAST, 2010) were taken into account.
Results
As already mentioned in the article of Cobbaut et al. (2009),
the 324 tested E. coli O157 isolates contained both the eaeA
gene and the ehxA gene. Twenty-nine isolates, originating
from eight farms, did not possess the vtx1 or the vtx2 genes. Of
the 295 isolates that had at least one of the vtx genes, 245 had
only vtx2 and 50 had both vtx1 and vtx2.
All isolates were typeable by PFGE and could be classified
into 83 distinguishable PFGE types. The majority of the PFGE
types (n¼ 76) were farm specific. Seven genotypes were de-
tected on more than one farm. Table 1 shows the distribution
of those PFGE types found on different farms. On farms with
more than one PFGE type (n¼ 22), a maximum of four PFGE
types were detected (Table 2). On half of these farms, one
PFGE type predominated.
The vtx-negative isolates originating from eight farms be-
longed to four different PFGE types, and one type (P53) was
shared by five farms (Table 1). In most cases, the isolates
originating from one farm harbored the same type of vtx
genes and had indistinguishable PFGE type. Nevertheless 17
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farms had isolates with different PFGE types although they
had the same vtx genes. On farm 9 one strain possessed the
vtx1 and vtx2 genes, whereas the other strains had only vtx2,
but they all belonged to the same PFGE type (P20).
The distribution of MIC values for the tested antimicrobial
agents is presented in Table 3. From the 116 isolates tested for
antimicrobial resistance, susceptibility to all the antimicrobial
agents was observed in 98 (84.5%) of the E. coli O157 isolates.
The remaining E. coli O157 isolates (n¼ 18), originating from
12 different cattle farms, were all resistant to streptomycin
and 16 also showed resistance to sulfisoxazole (Table 4). Six
isolates originating from three farms (21, 73, and 172) were
multiresistant (¼resistant to three or more antimicrobial
agents): in addition to streptomycin and sulfisoxazole, resis-
tance was observed to tetracycline (n¼ 4) and ampicillin and
trimethoprim (n¼ 2). One streptomycin-resistant isolate
should be considered as intermediately resistant to ampicillin,
chloramphenicol, and the combination amoxicillin–clavulanic
acid based on the CLSI breakpoints. Isolates showing anti-
microbial resistance and originating from the same farm all
had the same antimicrobial resistance profile (Table 4). On
three farms (11, 80, and 95) both susceptible and resistant
strains were isolated. Antimicrobial resistance was not de-
tected in the vtx-negative isolates.
The 18 antimicrobial-resistant strains showed 15 distin-
guishable PFGE types. The sensitive and resistant strains
originating from the same farm displayed discernable PFGE
types (farm 11, 80, and 95). From farms 21, 68 and 174 strains
were isolated belonging to at least two different PFGE types
without difference in antimicrobial resistance pattern (Table
4). Two strains, each originating from a different farm (174
and 176), shared the same PFGE type (P9), antimicrobial re-
sistance profile, and vtx genes.
Discussion
Identification of virulence factor genes demonstrated that
11.7% of the E. coli O157 isolates did not possess vtx genes,
although the other virulence genes tested were present. The
prevalence of vtx-negative E. coli O157 in cattle was similar to
data from other studies. Chapman et al. (1993) found 7% vtx-
negative E. coli O157 in fecal samples from cattle, and, more
recently, 8.9% of the E. coliO157were vtx-negative in a Danish
Table 1. Pulsed-Field Gel Electrophoresis Types
Present on At Least Two Farms and the Presence
of vtx Genes
PFGE
type vtx genes Farms
P9 vtx1þvtx2 174, 176
P20 vtx2a,b=(vtx1þvtx2)b 3, 9
P44 vtx2c,d=(vtx1þvtx2)d 137, 146
P49 vtx2 167, 168
P51 vtx2 24, 53, 100, 112, 165, 166, 175
P53 — 44, 101, 102, 104, 177
P74 vtx2 48, 56
avtx gene present in isolates from farm 3.
bvtx genes present in isolates from farm 9.
cvtx gene present in isolates from farm 137.
dvtx genes present in isolates from farm 146.
PFGE, pulsed-field gel electrophoresis.
Table 2. Farms with Two or More Pulsed-Field
Gel Electrophoresis Types: Correlation Between
Pulsed-Field Gel Electrophoresis Types, Presence=
Type of vtx Genes, and Farm Characteristics
Farm
Farm
type
No. of animals
purchaseda
PFGE type
(no. of isolates)
vtx
genes
9 Dairy 2 P20 (8) vtx2=vtx1þvtx2
P21(1) vtx2
11 Dairy 5 P17 (2) vtx1þvtx2
P42 (1) vtx2
21 Mixed 0 P11 (2) vtx2
P12 (1) vtx2
P23 (6) vtx2
24 Dairy 0 P51 (8) vtx2
P55 (1) vtx2
28 Beef 0 P35 (1) vtx2
P36 (1) vtx2
56 Dairy 0 P65 (6) vtx2
P68 (1) vtx2
P69 (1) vtx2
P70 (1) vtx2
66 Mixed 1 P6 (6) vtx1þvtx2
P7 (1) vtx1þvtx2
P8 (1) vtx1þvtx2
P10 (1) vtx1þvtx2
68 Beef 30 P14 (8) vtx1þvtx2
P15 (1) vtx1þvtx2
74 Dairy 0 P28 (4) vtx2
P29 (1) vtx2
P30 (1) vtx2
80 Mixed 1 P54 (3) vtx2
P73 (3) vtx1þvtx2
93 Mixed 0 P43 (6) vtx2
P47 (3) —
95 Dairy 0 P52 (1) vtx2
P56 (3) vtx2
104 Mixed 0 P53 (1) —
P67 (3) vtx2
P80 (1) vtx2
118 Mixed 20 P59 (2) vtx2
P60 (3) vtx2
134 Beef 80 P4 (5) vtx2
P16 (1) vtx1þvtx2
137 Dairy 0 P44 (1) vtx2
P45 (2) vtx2
P58 (3) vtx2
139 Beef 12 P1 (2) vtx1þvtx2
P2 (1) vtx1þvtx2
146 Mixed 0 P31 (2) vtx2
P32 (1) vtx2
P44 (2) vtx1þvtx2
156 Dairy 0 P74 (3) vtx2
P81 (3) vtx2
159 Beef 600 P13 (1) vtx2
P19 (2) —
P39 (3) vtx2
160 Beef 30 P46 (6) vtx2
P66 (2) vtx2
174 Beef 350 P9 (5) vtx1þvtx2
P34 (1) vtx2
aNumber of purchases within the year before the sampling day.
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study (Nielsen and Scheutz, 2002). It is unclear whether these
strains are evolutionary precursors or mutations of the pre-
dominant vtx-positive E. coli O157 strains.
The presence of only one or a small number of different
PFGE types on a farm is remarkable, since E. coli O157 can be
introduced into cattle farms by multiple sources. If incoming
cattle were the major source of E. coli O157, one might have
expected much more diversity among E. coli O157 isolates.
Possibly, certain E. coli O157 strain types are better adapted
for survival and persistence in the environment. Likewise,
Table 3. Distribution of the Minimal Inhibitory Concentration Values for 116 Escherichia coli
O157 Isolates Collected on Cattle Farms
No. of strains with minimal inhibitory concentrations (mg=mL)
Antimicrobial agent <0.03 0.03 0.06 0.125 0.25 0.5 1 2 4 8 16 32 64 128 >128
Ampicillina 1 110 2 1 2e
Amoxicillin=Clavulanic acida 7 105 3 1
Gentamicina 6 77 33
Trimethoprimc 3 90 20 1 2
Chloramphenicola 3 89 23 1
Sulfisoxazolea,b 47 53 16b
Ceftiofurc 11 104 1
Enrofloxacinc 12 103 1
Streptomycinc 2 96 7 9 2d
Tetracyclinea 3 109 4
Dashed vertical bars indicate breakpoints for susceptibility; full vertical bars indicate breakpoints for resistance.
aThe clinical breakpoints described by the CLSI standards were applied (CLSI, 2008). The clinical breakpoints for susceptibility and
resistance are represented by a discontinuous and a solid line, respectively.
bHigher concentrations were tested for sulfisoxazole, and all 16 isolates showed minimal inhibitory concentration values 512mg=mL,
which is the clinical breakpoint for resistance according to the CLSI (CLSI, 2008).
cThe wild-type cut-off values as described by the European Committee on Antimicrobial Susceptibility Testing (EUCAST, 2010) were
applied when no clinical breakpoints were available. The wild-type cut-off is represented by a solid line.
dStrains considered to have acquired resistance according to the European Committee on Antimicrobial Susceptibility Testing wild-type
cut-off are represented in italics.
eStrains considered to be resistant according to the clinical breakpoints of CLSI are represented in bold.
Table 4. Overview of the Antimicrobial Resistant Escherichia coli O157 Isolates, Expressed
by the Age Category of the Animals from Which They Were Isolated, and Their Corresponding
Pulsed-Field Gel Electrophoresis Type
Farm
Farm
type
PFGE
type
Age category of the cattle
at the origin of the isolatesa
Antimicrobial
resistance pattern
11 Diary P17 AþA =
P42 Cb,c Stþ (AmpþAmo=ClþChl)d
21 Mixed P11 AþA StþSuþTet
P12 B StþSuþTet
P23 AþBþBþCþCþC StþSuþTet
45 Diary P78 A StþSu
68 Beef P14 AþAþAþBþBþBþCþC StþSu
P15 C StþSu
73 Beef P25 AþAþA StþSuþTet
80 Mixed P54 CþCþC =
P73 BþBþB StþSu
95 Diary P52 B St
P56 CþCþC =
139 Beef P1 BþB StþSu
P2 B
170 Mixed P3 CþCþC StþSu
172 Beef P72 BþBþBþCþCþC StþSuþTriþAmp
174 Beef P9 AþAþAþBþB StþSu
P34 B StþSu
176 Mixed P9 CþCþC StþSu
aA: <8 months old; B: 8–30 months old; C: >30 months old.
bUnderlined¼ antimicrobial resistance tested.
cBold¼ resistant isolate.
dIntermediate resistance for the antibiotics mentioned between parentheses.
St, streptomycin; Su, sulfisoxazole; Tet, tetracycline; Tri, trimethoprim; Amp, ampicillin; Chl, chloramphenicol; Amo=Cl,
amoxicillinþ clavulanic acid.
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E. coliO157 isolates of a single PFGE type have been observed
to persist on farms from months to years (Shere et al., 1998;
Rice et al., 1999; Renter et al., 2003; Cobbaut et al., 2008). Per-
sistent infection and transmission between animals within a
farm are an alternative hypothesis to explain strain type sta-
bility. The fact that on most farms only a single PFGE type of
E. coli O157 could be isolated indicates that introduction and
establishment of a new E. coli O157 strain on cattle farms is
uncommon—either because an established farm strain is hard
to replace by new strains or because new strains are rarely
introduced on a farm.
A maximum of four different PFGE types were found in a
minority of the farms. Higher diversity has been described in
a study done in the United States, where up to seven different
subtypes were found in dairy and feedlot cattle farms (Rice
et al., 1999). In that study, open versus closed herd manage-
ment practices had no effect on the number of subtypes
present on dairy farms. Similarly, as no relationship was
found between the diversity of E. coli O157 subtypes and the
number of purchased animals in the present study, it can be
suggested that avoiding the entrance of new animals will not
prevent the introduction of E. coliO157 into the herd. Instead,
nonbovine sources such aswild animals, flies, and human and
vehicle movement may act as more important vehicles in the
introduction of E. coli O157.
Although most PFGE types are specific to one farm, some
strains appear to be more widespread, as indicated by the
presence of seven indistinguishable subtypes of E. coli O157
on different farms. Type P53was found on five farms ofwhich
three were in proximity. Two out of those farms belonged to
the same owner. Farms located in proximity might share
many common denominators, such as the bulk milk trans-
port, human travel, natural water systems, feed sources, and
nonbovine residing animals such as cats and dogs (Shere et al.,
1998), insects (Hancock et al., 1998), and direct contact with
wild animals (Wallace et al., 1997; Cı´zek et al., 1999; Sargeant
et al., 1999; Renter et al., 2004).
In the present study, 15.5% of the E. coli O157 isolates
showed resistance to at least one of the tested antimicrobial
agents. Galland et al. (2001) found a third of the bovine E. coli
O157 strains isolated in Kansas to be resistant to one or more
antimicrobial agents, whereas Meng et al. (1998) reported an
antimicrobial resistance prevalence of 24% for isolates of bo-
vine origin. Antimicrobial resistance of E. coli O157 was most
frequently detected to streptomycin (n¼ 18) and sulfisoxazole
(n¼ 16), followed by tetracycline (n¼ 4). This is in accordance
with other studies (Willshaw, 1996; Meng et al., 1998;
Schroeder et al., 2002; Cho et al., 2006). Age has been described
as a significant factor for gut colonization with antimicrobial-
resistant E. coli, with a higher prevalence of resistance dem-
onstrated in younger animals in surveys of cattle (De-
Francesco et al., 2004; Khachatryan et al., 2004). The data
indicate that beside the age of the animals, also the PFGE, the
vtx gene, and the farm type have no effect on the antimicrobial
resistance of E. coli O157 strains.
Veterinary use of antimicrobial agents may favor spread of
antimicrobial resistance in zoonotic bacteria and may pose a
human health hazard (Mølbak, 2006). Resistant bacteria from
food animals may enter the human population through the
food chain, and when causing illness, antimicrobial treatment
may not be successful. Although the role of early antimicro-
bial therapy in the prevention of HUS is still unclear (Griffin,
1995), surveillance of emerging antimicrobial resistance in
enterohemorrhagic E. coli is an important tool for future dis-
ease management programs ensuring public health.
Conclusion
The present study demonstrated that all E. coliO157 strains
isolated from cattle farms possess the eaeA and ehxA gene, but
somelacked vtx genes. PFGE typing showed that in a large
number of the farms, only one PFGE type was present.
However, some PFGE types seem to be widespread. Anti-
biotic resistance in E. coli O157 is still low and mainly due to
resistance to streptomycin and sulfisoxazole. Antibiotic re-
sistance was not related to certain PFGE types, the age of
animals, and the farm type.
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